Tessella plans to integrate Definiens' XD image-analysis software with the IT infrastructure of pharmaceutical and biotech companies.
NEW YORK (GenomeWeb News) — IT and consulting company Tessella has signed a systems integration partnership with Definiens under which it will implement the company's Definiens' XD image-analysis software at pharmaceutical and biotech companies.
Definiens, based in Munich, Germany, said today that Tessella also will independently market software that integrates the Defniens Cognition Network Technology, which is used to extract information from images.
"The partnership will expand our access to new markets and allow us to pursue larger clients for our premiere imaging-analysis technology," Manfred Voglmaier, Definiens' vice president of business development, said in a statement.
Financial terms of the deal were not disclosed.